Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CellPro and Northwestern University commence first BMT clinical trial in MS patients

June 7, 1996

Cytokine polypeptides described by Immunex

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Trials expected to begin on CoCensys' CCD-1042

June 7, 1996

Pfizer reports neuroleptics

June 7, 1996

Asahi Chem. claims sigma-receptor ligands

June 7, 1996

Transdermal buspirone covered under U.S. patent

June 7, 1996

Compounds with high affinity for 5-HT1A and/or D2 receptors reported by E. Merck

June 7, 1996

CCD-3693 clinical trials scheduled

June 7, 1996

Bristol-Myers Squibb describes compounds with melatonergic properties

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.